-
1
-
-
75849127328
-
Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009
-
Canonica GW, Bousquet J, Casale T et al. Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009. Allergy 2009; 64(Suppl. 91):1-59.
-
(2009)
Allergy
, vol.64
, pp. 1-59
-
-
Canonica, G.W.1
Bousquet, J.2
Casale, T.3
-
2
-
-
84876903600
-
Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report
-
e3.
-
Burks AW, Calderon MA, Casale T et al. Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. J Allergy Clin Immunol 2013; 131:1288-96.e3.
-
(2013)
J Allergy Clin Immunol
, vol.131
, pp. 1288-1296
-
-
Burks, A.W.1
Calderon, M.A.2
Casale, T.3
-
3
-
-
33846964159
-
Recommendations for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce
-
Canonica GW, Baena-Cagnani CE, Bousquet J et al. Recommendations for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy 2007; 62:317-24.
-
(2007)
Allergy
, vol.62
, pp. 317-324
-
-
Canonica, G.W.1
Baena-Cagnani, C.E.2
Bousquet, J.3
-
6
-
-
79955444722
-
Allergen-specific immunotherapy: which outcome measures are useful in monitoring clinical trials?
-
Pfaar O, Kleine-Tebbe J, Hormann K, Klimek L. Allergen-specific immunotherapy: which outcome measures are useful in monitoring clinical trials? Immunol Allergy Clin North Am 2011; 31:289-309.
-
(2011)
Immunol Allergy Clin North Am
, vol.31
, pp. 289-309
-
-
Pfaar, O.1
Kleine-Tebbe, J.2
Hormann, K.3
Klimek, L.4
-
7
-
-
78650873829
-
Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults
-
e2.
-
Nelson HS, Nolte H, Creticos P, Maloney J, Wu J, Bernstein DI. Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults. J Allergy Clin Immunol 2011; 127:72-80.e2.
-
(2011)
J Allergy Clin Immunol
, vol.127
, pp. 72-80
-
-
Nelson, H.S.1
Nolte, H.2
Creticos, P.3
Maloney, J.4
Wu, J.5
Bernstein, D.I.6
-
8
-
-
84870294264
-
Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE
-
Cox LS, Casale TB, Nayak AS et al. Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE. J Allergy Clin Immunol 2012; 130:1327-34.
-
(2012)
J Allergy Clin Immunol
, vol.130
, pp. 1327-1334
-
-
Cox, L.S.1
Casale, T.B.2
Nayak, A.S.3
-
9
-
-
77955813106
-
Five-grass pollen 300IR SLIT tablets: efficacy and safety in children and adolescents
-
Halken S, Agertoft L, Seidenberg J et al. Five-grass pollen 300IR SLIT tablets: efficacy and safety in children and adolescents. Pediatr Allergy Immunol 2010; 21:970-6.
-
(2010)
Pediatr Allergy Immunol
, vol.21
, pp. 970-976
-
-
Halken, S.1
Agertoft, L.2
Seidenberg, J.3
-
10
-
-
58849093549
-
Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment
-
Horak F, Jaeger S, Worm M, Melac M, Didier A. Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment. Clin Exp Allergy 2009; 39:394-400.
-
(2009)
Clin Exp Allergy
, vol.39
, pp. 394-400
-
-
Horak, F.1
Jaeger, S.2
Worm, M.3
Melac, M.4
Didier, A.5
-
11
-
-
58149121462
-
Agreement of efficacy assessments for five-grass pollen sublingual tablet immunotherapy
-
Didier A, Melac M, Montagut A, Lheritier-Barrand M, Tabar A, Worm M. Agreement of efficacy assessments for five-grass pollen sublingual tablet immunotherapy. Allergy 2009; 64:166-71.
-
(2009)
Allergy
, vol.64
, pp. 166-171
-
-
Didier, A.1
Melac, M.2
Montagut, A.3
Lheritier-Barrand, M.4
Tabar, A.5
Worm, M.6
-
12
-
-
58149109018
-
Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis
-
e3.
-
Wahn U, Tabar A, Kuna P et al. Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis. J Allergy Clin Immunol 2009; 123:160-6.e3.
-
(2009)
J Allergy Clin Immunol
, vol.123
, pp. 160-166
-
-
Wahn, U.1
Tabar, A.2
Kuna, P.3
-
13
-
-
84878353196
-
A phase 3 trial assessing the efficacy and safety of grass allergy immunotherapy tablet in subjects with grass pollen-induced allergic rhinitis with or without conjunctivitis, with or without asthma
-
Murphy K, Gawchik S, Bernstein D, Andersen J, Rud Pedersen M. A phase 3 trial assessing the efficacy and safety of grass allergy immunotherapy tablet in subjects with grass pollen-induced allergic rhinitis with or without conjunctivitis, with or without asthma. J Negat Results Biomed 2013; 12:10.
-
(2013)
J Negat Results Biomed
, vol.12
, pp. 10
-
-
Murphy, K.1
Gawchik, S.2
Bernstein, D.3
Andersen, J.4
Rud Pedersen, M.5
-
14
-
-
84880082661
-
A randomized, double-blind, placebo-controlled, parallel trial of standardized short ragweed (RW) sublingual allergy immunotherapy liquid extract (RW-SAIL) in adult subjects with ragweed-induced allergic rhinoconjunctivitis
-
Creticos P, Esch R, Couroux P et al. A randomized, double-blind, placebo-controlled, parallel trial of standardized short ragweed (RW) sublingual allergy immunotherapy liquid extract (RW-SAIL) in adult subjects with ragweed-induced allergic rhinoconjunctivitis. J Allergy Clin Immunol 2013; 131(2 Suppl):AB146.
-
(2013)
J Allergy Clin Immunol
, vol.131
, Issue.2 Suppl
, pp. AB146
-
-
Creticos, P.1
Esch, R.2
Couroux, P.3
-
15
-
-
67649210753
-
Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract
-
e1-5.
-
Amar SM, Harbeck RJ, Sills M, Silveira LJ, O'Brien H, Nelson HS. Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract. J Allergy Clin Immunol 2009; 124:150-6.e1-5.
-
(2009)
J Allergy Clin Immunol
, vol.124
, pp. 150-156
-
-
Amar, S.M.1
Harbeck, R.J.2
Sills, M.3
Silveira, L.J.4
O'Brien, H.5
Nelson, H.S.6
-
16
-
-
58149118102
-
Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study
-
Ott H, Sieber J, Brehler R et al. Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study. Allergy 2009; 64:1394-401.
-
(2009)
Allergy
, vol.64
, pp. 1394-1401
-
-
Ott, H.1
Sieber, J.2
Brehler, R.3
-
17
-
-
83755196755
-
Efficacy and safety of sublingual immunotherapy with grass monomeric allergoid: comparison between two different treatment regimens
-
Quercia O, Bruno ME, Compalati E, Falagiani P, Mistrello G, Stefanini GF. Efficacy and safety of sublingual immunotherapy with grass monomeric allergoid: comparison between two different treatment regimens. Eur Ann Allergy Clin Immunol 2011; 43:176-83.
-
(2011)
Eur Ann Allergy Clin Immunol
, vol.43
, pp. 176-183
-
-
Quercia, O.1
Bruno, M.E.2
Compalati, E.3
Falagiani, P.4
Mistrello, G.5
Stefanini, G.F.6
-
18
-
-
84857189488
-
Comparative effect of pre-coseasonal and continuous grass sublingual immunotherapy in children
-
Stelmach I, Kaluzinska-Parzyszek I, Jerzynska J, Stelmach P, Stelmach W, Majak P. Comparative effect of pre-coseasonal and continuous grass sublingual immunotherapy in children. Allergy 2012; 67:312-20.
-
(2012)
Allergy
, vol.67
, pp. 312-320
-
-
Stelmach, I.1
Kaluzinska-Parzyszek, I.2
Jerzynska, J.3
Stelmach, P.4
Stelmach, W.5
Majak, P.6
-
19
-
-
84869120896
-
High-dose sublingual immunotherapy with single-dose aqueous grass pollen extract in children is effective and safe: a double-blind, placebo-controlled study
-
e5.
-
Wahn U, Klimek L, Ploszczuk A et al. High-dose sublingual immunotherapy with single-dose aqueous grass pollen extract in children is effective and safe: a double-blind, placebo-controlled study. J Allergy Clin Immunol 2012; 130:886-93.e5.
-
(2012)
J Allergy Clin Immunol
, vol.130
, pp. 886-893
-
-
Wahn, U.1
Klimek, L.2
Ploszczuk, A.3
-
20
-
-
58149117614
-
Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy
-
e7.
-
Bufe A, Eberle P, Franke-Beckmann E et al. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy. J Allergy Clin Immunol 2009; 123:167-73.e7.
-
(2009)
J Allergy Clin Immunol
, vol.123
, pp. 167-173
-
-
Bufe, A.1
Eberle, P.2
Franke-Beckmann, E.3
-
21
-
-
73149111527
-
Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet
-
Durham SR, Emminger W, Kapp A et al. Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet. J Allergy Clin Immunol 2010; 125:131-8.
-
(2010)
J Allergy Clin Immunol
, vol.125
, pp. 131-138
-
-
Durham, S.R.1
Emminger, W.2
Kapp, A.3
-
22
-
-
58849141205
-
Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen
-
Stelmach I, Kaczmarek-Wozniak J, Majak P, Olszowiec-Chlebna M, Jerzynska J. Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen. Clin Exp Allergy 2009; 39:401-8.
-
(2009)
Clin Exp Allergy
, vol.39
, pp. 401-408
-
-
Stelmach, I.1
Kaczmarek-Wozniak, J.2
Majak, P.3
Olszowiec-Chlebna, M.4
Jerzynska, J.5
-
23
-
-
78650920807
-
Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents
-
e4.
-
Blaiss M, Maloney J, Nolte H, Gawchik S, Yao R, Skoner DP. Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents. J Allergy Clin Immunol 2011; 127:64-71.e4.
-
(2011)
J Allergy Clin Immunol
, vol.127
, pp. 64-71
-
-
Blaiss, M.1
Maloney, J.2
Nolte, H.3
Gawchik, S.4
Yao, R.5
Skoner, D.P.6
-
24
-
-
84878215291
-
Randomized controlled trial of ragweed allergy immunotherapy tablet efficacy and safety in North American adults
-
e4.
-
Nolte H, Hebert J, Berman G et al. Randomized controlled trial of ragweed allergy immunotherapy tablet efficacy and safety in North American adults. Ann Allergy Asthma Immunol 2013; 110:450-6.e4.
-
(2013)
Ann Allergy Asthma Immunol
, vol.110
, pp. 450-456
-
-
Nolte, H.1
Hebert, J.2
Berman, G.3
-
25
-
-
80052259321
-
Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis
-
Didier A, Worm M, Horak F et al. Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis. J Allergy Clin Immunol 2011; 128:559-66.
-
(2011)
J Allergy Clin Immunol
, vol.128
, pp. 559-566
-
-
Didier, A.1
Worm, M.2
Horak, F.3
-
26
-
-
77649274006
-
Sublingual immunotherapy in patients with allergic rhinoconjunctivitis caused by ragweed pollen
-
Skoner D, Gentile D, Bush R, Fasano MB, McLaughlin A, Esch RE. Sublingual immunotherapy in patients with allergic rhinoconjunctivitis caused by ragweed pollen. J Allergy Clin Immunol 2010; 125:660-6.
-
(2010)
J Allergy Clin Immunol
, vol.125
, pp. 660-666
-
-
Skoner, D.1
Gentile, D.2
Bush, R.3
Fasano, M.B.4
McLaughlin, A.5
Esch, R.E.6
-
28
-
-
84876906083
-
Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults
-
e6.
-
Creticos PS, Maloney J, Bernstein DI et al. Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults. J Allergy Clin Immunol 2013; 131:1342-9.e6.
-
(2013)
J Allergy Clin Immunol
, vol.131
, pp. 1342-1349
-
-
Creticos, P.S.1
Maloney, J.2
Bernstein, D.I.3
-
29
-
-
84857797855
-
SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial
-
e5.
-
Durham SR, Emminger W, Kapp A et al. SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. J Allergy Clin Immunol 2012; 129:717-25.e5.
-
(2012)
J Allergy Clin Immunol
, vol.129
, pp. 717-725
-
-
Durham, S.R.1
Emminger, W.2
Kapp, A.3
-
31
-
-
79955375673
-
The average Adjusted Symptom Score, a new primary efficacy end-point for specific allergen immunotherapy trials
-
Grouin JM, Vicaut E, Jean-Alphonse S et al. The average Adjusted Symptom Score, a new primary efficacy end-point for specific allergen immunotherapy trials. Clin Exp Allergy 2011; 41:1282-8.
-
(2011)
Clin Exp Allergy
, vol.41
, pp. 1282-1288
-
-
Grouin, J.M.1
Vicaut, E.2
Jean-Alphonse, S.3
-
32
-
-
33947170595
-
Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines
-
Bousquet PJ, Combescure C, Neukirch F et al. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy 2007; 62:367-72.
-
(2007)
Allergy
, vol.62
, pp. 367-372
-
-
Bousquet, P.J.1
Combescure, C.2
Neukirch, F.3
-
33
-
-
84881015437
-
Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis
-
Demoly P, Bousquet PJ, Mesbah K, Bousquet J, Devillier P. Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis. Clin Exp Allergy 2013; 43:881-8.
-
(2013)
Clin Exp Allergy
, vol.43
, pp. 881-888
-
-
Demoly, P.1
Bousquet, P.J.2
Mesbah, K.3
Bousquet, J.4
Devillier, P.5
-
34
-
-
77950853694
-
Olea sublingual allergoid immunotherapy administered with two different treatment regimens
-
Leonardi S, Arena A, Bruno ME et al. Olea sublingual allergoid immunotherapy administered with two different treatment regimens. Allergy Asthma Proc 2010; 31:e25-9.
-
(2010)
Allergy Asthma Proc
, vol.31
, pp. e25-e29
-
-
Leonardi, S.1
Arena, A.2
Bruno, M.E.3
-
35
-
-
84883053892
-
Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial
-
Aydogan M, Eifan AO, Keles S et al. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial. Respir Med 2013; 107:1322-9.
-
(2013)
Respir Med
, vol.107
, pp. 1322-1329
-
-
Aydogan, M.1
Eifan, A.O.2
Keles, S.3
-
36
-
-
84858795651
-
Sublingual immunotherapy not effective in house dust mite-allergic children in primary care
-
de Bot CM, Moed H, Berger MY et al. Sublingual immunotherapy not effective in house dust mite-allergic children in primary care. Pediatr Allergy Immunol 2012; 23:150-8.
-
(2012)
Pediatr Allergy Immunol
, vol.23
, pp. 150-158
-
-
de Bot, C.M.1
Moed, H.2
Berger, M.Y.3
-
37
-
-
79953659894
-
House dust mite sublingual immunotherapy: results of a US trial
-
e1-7.
-
Bush RK, Swenson C, Fahlberg B et al. House dust mite sublingual immunotherapy: results of a US trial. J Allergy Clin Immunol 2011; 127:974-81.e1-7.
-
(2011)
J Allergy Clin Immunol
, vol.127
, pp. 974-981
-
-
Bush, R.K.1
Swenson, C.2
Fahlberg, B.3
-
38
-
-
84861129636
-
Clinical efficacy of sublingual immunotherapy in pediatric patients with allergic rhinitis sensitized to house dust mites: comparison to adult patients
-
Han DH, Choi YS, Lee JE et al. Clinical efficacy of sublingual immunotherapy in pediatric patients with allergic rhinitis sensitized to house dust mites: comparison to adult patients. Acta Otolaryngol 2012; 132(Suppl. 1):S88-93.
-
(2012)
Acta Otolaryngol
, vol.132
, pp. S88-S93
-
-
Han, D.H.1
Choi, Y.S.2
Lee, J.E.3
-
39
-
-
77955607935
-
Clinical and immunologic effects of sublingual immunotherapy on patients with allergic rhinitis to house-dust mites: 1-year follow-up results
-
Kim ST, Han DH, Moon IJ, Lee CH, Min YG, Rhee CS. Clinical and immunologic effects of sublingual immunotherapy on patients with allergic rhinitis to house-dust mites: 1-year follow-up results. Am J Rhinol Allergy 2010; 24:271-5.
-
(2010)
Am J Rhinol Allergy
, vol.24
, pp. 271-275
-
-
Kim, S.T.1
Han, D.H.2
Moon, I.J.3
Lee, C.H.4
Min, Y.G.5
Rhee, C.S.6
-
40
-
-
79959764256
-
Efficacy of sublingual immunotherapy with house dust mite extract in polyallergen sensitized patients with allergic rhinitis
-
Lee JE, Choi YS, Kim MS et al. Efficacy of sublingual immunotherapy with house dust mite extract in polyallergen sensitized patients with allergic rhinitis. Ann Allergy Asthma Immunol 2011; 107:79-84.
-
(2011)
Ann Allergy Asthma Immunol
, vol.107
, pp. 79-84
-
-
Lee, J.E.1
Choi, Y.S.2
Kim, M.S.3
-
41
-
-
84878143522
-
Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial
-
Wang DH, Chen L, Cheng L et al. Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial. Laryngoscope 2013; 123:1334-40.
-
(2013)
Laryngoscope
, vol.123
, pp. 1334-1340
-
-
Wang, D.H.1
Chen, L.2
Cheng, L.3
-
42
-
-
78649981810
-
Days with severe symptoms: an additional efficacy endpoint in immunotherapy trials
-
Durham SR, Birk AO, Andersen JS. Days with severe symptoms: an additional efficacy endpoint in immunotherapy trials. Allergy 2011; 66:120-3.
-
(2011)
Allergy
, vol.66
, pp. 120-123
-
-
Durham, S.R.1
Birk, A.O.2
Andersen, J.S.3
-
43
-
-
0031838266
-
Immunotherapy as an effective tool in allergy treatment
-
Malling HJ. Immunotherapy as an effective tool in allergy treatment. Allergy 1998; 53:461-72.
-
(1998)
Allergy
, vol.53
, pp. 461-472
-
-
Malling, H.J.1
-
44
-
-
33744758057
-
Sublingual immunotherapy: efficacy-methodology and outcome of clinical trials
-
Malling HJ. Sublingual immunotherapy: efficacy-methodology and outcome of clinical trials. Allergy 2006; 61(Suppl. 81):24-8.
-
(2006)
Allergy
, vol.61
, pp. 24-28
-
-
Malling, H.J.1
-
45
-
-
76749093073
-
Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by class
-
Benninger M, Farrar JR, Blaiss M et al. Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by class. Ann Allergy Asthma Immunol 2010; 104:13-29.
-
(2010)
Ann Allergy Asthma Immunol
, vol.104
, pp. 13-29
-
-
Benninger, M.1
Farrar, J.R.2
Blaiss, M.3
-
46
-
-
84855565794
-
Placebo effect in clinical trials involving patients with allergic rhinitis
-
del Cuvillo A, Sastre J, Bartra J et al. Placebo effect in clinical trials involving patients with allergic rhinitis. J Investig Allergol Clin Immunol 2011; 21(Suppl. 3):40-5.
-
(2011)
J Investig Allergol Clin Immunol
, vol.21
, pp. 40-45
-
-
del Cuvillo, A.1
Sastre, J.2
Bartra, J.3
-
47
-
-
84927549859
-
-
eds. London, UK: European Academy of Allergology and Clinical Immunology
-
Durham SR, Dahl R, Kapp A et al., eds. Sustained, disease-modifying effect of grass allergen tablet immunotherapy 2 years after end of treatment. London, UK: European Academy of Allergology and Clinical Immunology, 2010.
-
(2010)
Sustained, disease-modifying effect of grass allergen tablet immunotherapy 2 years after end of treatment
-
-
Durham, S.R.1
Dahl, R.2
Kapp, A.3
-
48
-
-
84876702869
-
Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis
-
Didier A, Malling HJ, Worm M et al. Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis. Clin Exp Allergy 2013; 43:568-77.
-
(2013)
Clin Exp Allergy
, vol.43
, pp. 568-577
-
-
Didier, A.1
Malling, H.J.2
Worm, M.3
|